LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2015

Feb 9, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2015-02-05

Reporting Person: MAIN ALAN J (EVP, Pharmaceutical Research)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-05	Restricted Stock Units (Phantom Stock)	$	A	147600	Acquired		Common Stock (147600)	Direct
2015-02-05	Stock Option (Right to Buy)	$.89	A	590400	Acquired	2025-02-05	Common Stock (590400)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

F3: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/5/16) and vests 1/48th per month for each month of service thereafter.